These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30810454)

  • 21. Analysis of longitudinal clinical trials with missing data using multiple imputation in conjunction with robust regression.
    Mehrotra DV; Li X; Liu J; Lu K
    Biometrics; 2012 Dec; 68(4):1250-9. PubMed ID: 22994905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistics review 10: further nonparametric methods.
    Bewick V; Cheek L; Ball J
    Crit Care; 2004 Jun; 8(3):196-9. PubMed ID: 15153238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA; Wu R; Tiwari RC
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Note on special technical issue on adaptive designs for clinical trials.
    Liu Q; Chang M
    J Biopharm Stat; 2012; 22(4):615-6. PubMed ID: 22651104
    [No Abstract]   [Full Text] [Related]  

  • 25. Methods to assess an exercise intervention trial based on 3-level functional data.
    Li H; Kozey Keadle S; Staudenmayer J; Assaad H; Huang JZ; Carroll RJ
    Biostatistics; 2015 Oct; 16(4):754-71. PubMed ID: 25987650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subgroup analysis based on structured mixed-effects models for longitudinal data.
    Shen J; Qu A
    J Biopharm Stat; 2020 Jul; 30(4):607-622. PubMed ID: 32126871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.
    Jiang Z; Song Y; Shou Q; Xia J; Wang W
    Trials; 2014 Dec; 15():500. PubMed ID: 25528466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A mixture model with random-effects components for clustering correlated gene-expression profiles.
    Ng SK; McLachlan GJ; Wang K; Ben-Tovim Jones L; Ng SW
    Bioinformatics; 2006 Jul; 22(14):1745-52. PubMed ID: 16675467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Qualitative and mixed methods research in trials.
    Snowdon C
    Trials; 2015 Dec; 16():558. PubMed ID: 26646545
    [No Abstract]   [Full Text] [Related]  

  • 30. Test for the consistency of noninferiority from multiple clinical trials.
    Yan X; Wang MC; Su X
    J Biopharm Stat; 2007; 17(2):265-78. PubMed ID: 17365223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applying sample survey methods to clinical trials data.
    LaVange LM; Koch GG; Schwartz TA
    Stat Med; 2001 Sep 15-30; 20(17-18):2609-23. PubMed ID: 11523072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group sequential methods for cluster randomization trials with binary outcomes.
    Zou GY; Donner A; Klar N
    Clin Trials; 2005; 2(6):479-87. PubMed ID: 16422308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and monitoring of survival trials based on restricted mean survival times.
    Luo X; Huang B; Quan H
    Clin Trials; 2019 Dec; 16(6):616-625. PubMed ID: 31450951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part II: proofs of results.
    Orellana L; Rotnitzky A; Robins JM
    Int J Biostat; 2010 Mar; 6(2):Article 9. PubMed ID: 20405047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonparametric clustering for longitudinal functional data with the application to H-NMR spectra of kidney transplant patients. Longitudinal functional data clustering.
    Xie M; Liu H; Houwing-Duistermaat J
    Theor Biol Forum; 2021 Jan; 114(1-2):15-28. PubMed ID: 35502728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On model selections for repeated measurement data in clinical studies.
    Zou B; Jin B; Koch GG; Zhou H; Borst SE; Menon S; Shuster JJ
    Stat Med; 2015 May; 34(10):1621-33. PubMed ID: 25645442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bayesian sample size determination for longitudinal studies with continuous response based on different scientific questions of interest.
    Baghfalaki T
    J Biopharm Stat; 2019; 29(2):244-270. PubMed ID: 30359549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wilcoxon-Mann-Whitney test: stratify or not?
    Qu Y; Zhao YD; Rahardja D
    J Biopharm Stat; 2008; 18(6):1103-11. PubMed ID: 18991110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneous growth bent-cable models for time-to-event and longitudinal data: application to AIDS studies.
    Dagne GA
    J Biopharm Stat; 2018; 28(6):1216-1230. PubMed ID: 29953318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.